Check Cytokinetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.7B
EPS (TTM)
-5.6178
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-12.38
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
-0.42
EBITDA
-537.6M
Revenue (TTM)
85.7M
Profit Margin
0.00%
Return On Equity TTM
151500.00%
Track how Cytokinetics Inc P/E has moved over time to understand its valuation trends.
Cytokinetics Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Today (-12.38x)
September 18, 2025
Industry (10.13x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: -12.38x
Compare market cap, revenue, PE, and other key metrics of Cytokinetics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $5.7B | 118.12% | -12.38 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Cytokinetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cytokinetics Inc investment value today
Current value as on today
₹89,937
Returns
Returns from Cytokinetics Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 25 analysts
84.00%
Buy
16.00%
Hold
0.00%
Sell
Based on 25 analysts, 84% of analysts recommend a 'BUY' rating for Cytokinetics Inc. Average target price of $74.41
Get share price movements and forecasts by analysts on Cytokinetics Inc.
What analysts predicted
36.11%UPSIDE
Target Price
$74.41
Current Price
$47.54
Analyzed by
25 Analysts
Target
$74.41
Cytokinetics Inc target price $74.41, a slight upside of 36.11% compared to current price of $47.54. According to 25 analysts rating.
Investment in Cytokinetics Inc Shares on INDmoney has grown by 362.50% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:362.50% versus previous 30 day period
Search interest for Cytokinetics Inc Stock has increased by 223% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:223% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 September
Wed, 09:30 PM
-Cytokinetics stock fell over 1% after announcing $650 million convertible senior notes due in 2031.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 1.57M → 66.76M (in $), with an average increase of 97.6% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -161.37M → -134.37M (in $), with an average increase of 20.1% per quarter
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 83.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 122.4%
Price Dip
In the last 7 days, CYTK stock has moved down by -10.8%
Organisation | Cytokinetics Inc |
Headquarters | 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Mr. Robert I. Blum |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Kari K. Loeser J.D. | VP & Chief Compliance Officer |
Mr. John O. Faurescu Esq., J.D. | Senior VP, Deputy General Counsel & Corporate Secretary |
Mr. Robert I. Blum | CEO, President & Director |
Dr. James A. Spudich Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Ms. Holly Laughlin | VP of Accounting & Corporate Controller |
Mr. Steven M. Cook J.D. | Senior Vice President of Global Supply Chain Operations & Technical Operations |
Mr. Sung H. Lee | EVP & CFO |
Dr. Fady Ibraham Malik FACC, M.D., Ph.D. | Executive Vice President of Research & Development |
Mr. Andrew M. Callos | Executive VP & Chief Commercial Officer |
Mr. Jeff Lotz | Vice President of Sales & Operations |
Cytokinetics Inc share price today is $47.54 as on . Cytokinetics Inc share today touched a day high of $48.72 and a low of $47.34.
Cytokinetics Inc share touched a 52 week high of $59.39 on and a 52 week low of $29.31 on . Cytokinetics Inc stock price today i.e. is trending at $47.54,which is 19.95% down from its 52 week high and 62.20% up from its 52 week low.
Cytokinetics Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Cytokinetics Inc (CYTK) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Cytokinetics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cytokinetics Inc share’s latest price of $47.54 as on September 18, 2025 at 9:38 pm IST, you will get 0.2103 shares of Cytokinetics Inc. Learn more about
fractional shares .
Cytokinetics Inc stock has given 118.12% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?